Medical News

RSS

Breckenridge acquires Cypress Pharmaceutical product assets from Pernix Therapeutics

Breckenridge Pharmaceutical, Inc. announced today that it has completed its acquisition of certain Cypress Pharmaceutical, Inc. product assets from Pernix Therapeutics. The assets include 11 Abbreviated New Drug Applications filed with the FDA, certain ANDAs in various stages of development, as well as 6 already-approved and marketed products.

12 Sep 2013

New study shows advances in care for women who suffer from recurrent miscarriage

A team of researchers, led by the University of Warwick, have published new data that could prove vital for advances in care for women who suffer from recurrent miscarriage.

12 Sep 2013

Professors receive 100,000 Euro from Hartwig Piepenbrock-DZNE for outstanding brain research

The prize is awarded by the Piepenbrock Group and the German Center for Neurodegenerative Diseases (DZNE). The award ceremony will be held in Berlin on September 24, 2013.

12 Sep 2013

North Carolina professor receives 2013 New Scholar in Aging Award from Ellison Medical Foundation

Li Qian, PhD, an assistant professor in the University of North Carolina School of Medicine, has received a 2013 New Scholar in Aging Award from the Ellison Medical Foundation.

12 Sep 2013

Alert to CAM use in asthma

Researchers from Canada say that physicians should be aware of the high prevalence of complementary and alternative medicine use among patients with asthma.

11 Sep 2013

High-risk youths need help regardless of psychosis conversion

Young people at clinical high risk for psychosis often have poor outcomes even if they do not actually develop psychosis, a study shows.

11 Sep 2013

Gender warns of bipolar I disorder risks

Researchers have confirmed several features that differ between men and women with bipolar disorder, which may impact on the course and treatment of the condition.

11 Sep 2013

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

...

11 Sep 2013

Hedgepath, Mayne Repurposing Fungal Infection Drug For Cancer

...

11 Sep 2013

Elsevier collaborates with EI in organizing first Energy Systems conference to be held on June 2014, London

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced its official collaboration with the Energy Institute (EI) in organizing the first Energy Systems conference to be held 24-25 June 2014 in London.

11 Sep 2013

Medflow chooses DataMotion Direct secure messaging service for exchange of PHI

DataMotion, an innovative health information service provider with more than 14 years of experience in secure data delivery, today announced that Medflow, Inc., the leading provider of electronic health records for ophthalmology, has selected its DataMotion Direct secure messaging service.

11 Sep 2013

Perkins+Will completes UF's Clinical and Translational Research Building

The Miami office of global architecture and design firm, Perkins+Will, recently completed a major healthcare, education and research project, the University of Florida's Clinical and Translational Research Building.

11 Sep 2013

Study suggests new path to make protective malaria vaccine

This study suggests that genetically engineered malaria parasites that are stunted through precise gene deletions (genetically attenuated parasites, or "GAP") could be used as a vaccine that protects against malaria infection. This means that the harmless (attenuated) version of the parasite would interact with the body in the same way as the infective version, but without possibility of causing disease.

11 Sep 2013

MicroBiome Therapeutics' NM504 eliminates diarrhea caused by metformin in type 2 diabetes patient

MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.

11 Sep 2013

First Edition: September 11, 2013

Today's headlines include reports that some House GOP lawmakers are taking a hard line against funding for the health law in the ongoing debate about raising the nation's debt limit.

11 Sep 2013

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

Glioblastoma is the most common ma-lignant primary brain tumor in adults. The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide.

11 Sep 2013

University student shares experiences about managing severe allergy

Ahead of the first term back for university undergraduates this month, the Anaphylaxis Campaign has released a short film on their YouTube channel.

11 Sep 2013

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine’s efficacy in treating asthma patients and is not currently approved for this indication.

11 Sep 2013

Better ways to combat mosquitoes

In an advance toward providing mosquito-plagued people, pets and livestock with an invisibility cloak against these blood-sucking insects, scientists today described discovery of substances that occur naturally on human skin and block mosquitoes’ ability to smell and target their victims.

11 Sep 2013

New advances toward making molecular prosthetics a reality

The vision for a new branch of medicine, inspired by the ancient field that began with peg legs and hand hooks, commanded the spotlight in a major address by its pioneer here today at the 246th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society.

11 Sep 2013